A quiet change in SB2402 gives pharmacists new authority to swap medications—and it affects how prescribers and pharmacies will need to work together.
Most health service owners in North Dakota don't realize that a provision buried in SB2402 has fundamentally changed what pharmacists can do at the point of dispensing—without asking permission first.
Effective upon filing with the Secretary of State (expected in 2026), Section 4 of SB2402 permits pharmacists to substitute a therapeutically equivalent drug with a different active ingredient in place of what was originally prescribed. This is not a minor administrative tweak. It's a shift in pharmacy practice authority that affects independent pharmacies, chain operations, and the prescribers who work with them.
Under the new rule, a pharmacist may dispense a therapeutically equivalent alternative drug without prior approval from the prescriber, provided three conditions are met:
1. Verbal counseling: The pharmacist must counsel the patient about the substitution.
2. Documented benefit: The pharmacist must confirm that the substitution offers either a cost benefit or an access benefit to the patient.
3. Prescriber notification: The pharmacist must notify the prescriber electronically within 24 hours of the substitution.
The notification happens after the fact, not before. This is the critical distinction from prior practice in North Dakota.
Pharmacies—particularly independent and smaller operations—now have discretion to manage formulary issues, insurance coverage gaps, and patient affordability in real time. Prescribers should expect to receive electronic notifications about substitutions after they occur, not requests for approval beforehand.
For health service owners, this means:
Operational changes: Pharmacy staff need clear protocols for documenting the benefit (cost or access), conducting counseling, and sending timely electronic notifications to prescribers.
Prescriber communication: If you operate a clinic or medical practice, you'll want to establish a system for receiving and reviewing these 24-hour notifications. It's not a veto mechanism—it's a heads-up that a substitution has occurred.
Patient safety: The requirement for verbal counseling and documented benefit is designed to protect patients, but it also creates a record. Pharmacies should ensure their counseling and benefit documentation are clear and defensible.
Revenue and access: For pharmacies, this creates new opportunity to resolve coverage denials and cost barriers without delay. For prescribers, it means less administrative friction around formulary issues—but also less control over which specific drug reaches the patient.
The effective date is upon filing with the Secretary of State. While the exact filing date has not been publicly announced, health service owners should plan for implementation in 2026. This is a good time to review your current prescriber-pharmacy communication workflows and consider whether your electronic notification systems are ready.
SB2402 is a real change with real workflow implications. It's worth understanding now, before it takes effect.
Source: SB2402, Section 4, Page 8, State of North Dakota Legislature.